Skip to main content

Table 1 Frequency distribution of enrolled study population, HBV prevalence in each step of HBV screening among study groups

From: Molecular epidemiology of hepatitis B virus among HIV co-infected and mono-infected cohorts in Northwest Ethiopia

HBV test done

Study groups, n (%)

HIV positive

Blood donors

Liver disease patients

Enrollment

2133 (52.0)

1720 (41.9)

252 (6.1)

HBsAg positive

143 (6.7)

145 (8.4)

109 (43.3)

HBV DNA positive

71 (55.5)a

82 (79.6)a

98 (89.9)

Sequenced

62 (87.3)

56 (68.3)

59 (60.2)

Total (genotyped)

 

177* (70.5)

 
  1. aHBsAg positive sera (15 from HIV positive and 42 from blood donors) were not considered in the next HBV DNA extraction step due to low sera volume. Therefore, the HBV DNA positivity rates were calculated from 128 and 109 sera of HIV positive individuals and blood donors, respectively. *Overall, 180 HBV genotyped cases reproted in the result section by including 3 cases from OHB infection (Table 3)
Back to article page

Virology Journal

ISSN: 1743-422X